© 2021 NESTED BIO. All rights reserved.
Menu
Managing Director
Lic.Engg. in Microfluidic Systems (Lund University, Sweden); M.Tech. in Nanobiotech (JIIT, Noida, India).
Punyani is a serial entrepreneur, a founder of and inventor behind over 5 tech startups in Sweden since 2018. He has a keen interest in launching novel and disruptive products in medtech, pharmaceuticals and cleantech.
CEO, Prolevi Bio AB
Sahil Gupta has a PhD from Goethe University Frankfurt with over 10 years of R&D experience in life sciences, immunology, and genetic engineering.
After a short residence at Nested Bio, Sahil founded Prolevi Bio AB in Dec 2021 with a co-investment from Nested Bio AB.
Ph.D. in Cancer Biology/Biomedical Sciences (Lund University, Sweden); M.Sc. Molecular Biology and Genetics & B.Sc. Health Sciences (University of Lisbon, Portugal).
Cabrita manages Nested Bio’s deal flow process, assessing all incoming opportunities and in-depth research during due diligence. Rita is a trained academic researcher in cancer biology and published in reputable journals such as Nature and Cell Press.
Principal Scientist at Spermosens AB
Tertiary lymphoid structures improve immunotherapy and survival in melanoma. 2020, Nature.
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma. 2020, Molecular Oncology.
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response. 2020, Cancers.
NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling. 2019, Oncogene.
The X-linked DDX3X RNA helicase dictates translation reprogramming and metastasis in melanoma. 2019, Cell Reports.
If you are looking for financing and management advice for your startup, or just have a cool idea, feel free to contact!
MEDICON VILLAGE
Scheeletorget 1
223 81 Lund, Sweden
© 2021 NESTED BIO. All rights reserved.